• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement

by Christopher Ianelli, MD, Ph.D., Founder & CEO of iSpecimen 08/02/2022 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement
Christopher Ianelli, MD, Ph.D., Founder & CEO of iSpecimen

Many medical advancements – from life-saving vaccines and treatments to new diagnostic tests like liquid biopsies – are built on research that involves human biospecimens. Biofluids, tissue and cells are indispensable resources for the medical researcher, yet the process of sourcing these biospecimens can be woefully frustrating and inefficient. These challenges can have a direct, negative impact on the pace of discovery, creating urgency for improved access to the biospecimens researchers need to advance their important work.

In fact, as far back as 2008, 4 in 5 researchers said they needed to limit the scope of their work due to difficulties obtaining biospecimens. In our own survey of researchers this year, more than three in four found it somewhat to very difficult to find the type and quantity of specimens they need; seven out of 10 found it somewhat to very difficult to obtain the quality of specimens they need; two in three found it somewhat to very difficult to find sample providers at all.

Who has the specimens a researcher needs?

The specimen-matching market consists of millions of healthcare providers that could potentially offer biospecimens and associated data for research, and possibly hundreds of thousands of life science researchers around the world who need access to them. Unfortunately, this market remains frustratingly fragmented. 

Healthcare organizations that already possess (or can quickly acquire) certain biospecimens don’t know exactly which researchers need which of their specimens. Furthermore, researchers, once they’ve decided exactly which specimens they need, don’t know which suppliers can provide those specimens. So how do they discover each other? The parties still commonly use email and phone calls to familiar partners to help find needed specimens from banked inventories or custom collections when existing samples do not match up with the specific sample and data requirements. In other cases, they search the web supplier by supplier, specimen by the specimen. Often, organizations that could help each other don’t realize the other exists.

You might think that modern technology would have brought the suppliers and users closer together, but matching specimen supply to demand is a moving target. That’s because precision medicine requires ever-more-specific biospecimens.

Consider that in the past, a cancer researcher might have been able to complete his or her work using any 50 breast cancer tissue specimens. But today, that researcher is zeroing in on subtypes of disease and might reasonably need 50 samples of tumor tissue from patients with metastatic, HER2-positive breast cancer, with a HER2 L755S mutation, refractory to treatment with Herceptin. Other sorting characteristics are important as well, including patient age, gender, race, condition, severity, blood type, past procedures, test results, outcomes, smoking status, family history and more.

Make specimen matching more like e-commerce

The specimen supply chain is only now just beginning to benefit from some of the efficiencies of consumer commerce, where suppliers of essential products display all their wares online, providing powerful search and easy online ordering tools. Buyers are starting to find good online sources for what they need.

The ultimate solution to precision specimen matching is a technology that streamlines complex procurement much like how Amazon.com makes it easy to buy office equipment, clothes and food in a few clicks, or, say, Kayak.com makes it easy to arrange a flight, rental car and motel. Such an online marketplace paradigm could transform the fragmented landscape into a single online global biobank. 

Here are the technology components we will need:

Search 

An online marketplace for biospecimens would require the same ease-of-use characteristics that business-to-consumer marketplaces offer. These attributes start with simple guided searches, the ability to refine search criteria with sliders and checkboxes and the ability to add chosen items to a cart in order to purchase them.

Researchers in a high-functioning marketplace would be able to discover not only banked specimens but records of patients who may be able to provide specific biospecimens upon request. The matching technology would need to scour the inventories of a wide range of participating providers, including clinical labs, pathology labs, biorepositories, blood donor centers and clinical research centers worldwide. Researchers could see both banked specimens that exist in inventory as well as the prospective availability of specimens that could be collected when needed.

Workflow

The marketplace platform would need to easily integrate into researcher and supplier environments to automate key parts of the procurement workflow. The technology would enable suppliers to track and manage all of their specimen requests from feasibility assessment through ordering and fulfillment through a single web dashboard. The workflow would need to be easy and intuitive so that it doesn’t siphon supplier resources from their primary roles of responsibility. It would need to be just as easy for researchers to track their orders from source to arrival. Today, these functions are often managed manually with spreadsheets, which is time-consuming and error-prone.

Data Integration

The biospecimen marketplace would rely on the integration of de-identified medical records of patient populations in supplier networks. The records would supply robust data about patients, specimens, lab results and medical conditions. The data, which would be in different formats and quality levels, would be in accordance with HIPAA and other applicable regulations that protect patient privacy. Integration would be based on commonly used healthcare data formats such as HL7, JSON files and CSV files that would be normalized and harmonized into standard terminology sets.

Compliance

One of the most important, complex and time-consuming processes in specimen use is compliance: ensuring that specimens are ethically collected and used and that patients are protected. To be truly effective in streamlining biospecimen matching and use, the platform would need to automate, to the extent possible, the tracking and management of unique regulatory and legal requirements across customers and suppliers. The system would need to match such conditions as consent requirements versus patient consents granted; required specimen and data use versus the supplier’s allowed specimen and data use, and resale or distribution requirements versus resale or distribution rights.

Although significant work is needed to improve and streamline the biospecimen procurement process, the industry is starting to make progress. Researchers are getting more tools for specimen procurement, and specimen suppliers are treating their biobanks more than ever as cost-recovery businesses, and researchers as customers. Although medicine isn’t a conventional business, technology can help untangle the vital supply chains that provide required specimens to the researchers who need them. The solution includes a procurement ecosystem that enables technology to bring researchers and specimen suppliers together to efficiently and compliantly fulfill the increase of demand. Medical progress depends on it. 

About Christopher Ianelli

Christopher Ianelli, MD, Ph.D., is the founder and chief executive officer of iSpecimen, a global, online marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare providers who have them.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Amazon, Breast Cancer, cancer, clinical research, Data Integration, Healthcare Data, HIPAA, HL7, Human Biospecimens, iSpecimen, MD, medical records, Partners, patient privacy, PhD, Precision Medicine, Vital

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

5 Ways New Trump Administration Tariffs Are Impacting U.S. Healthcare Now

5 Ways Trump Administration Tariffs Are Impacting U.S. Healthcare Now

iCAD, GE HealthCare Integrate to Advance Breast Cancer Detection with AI

RadNet to Acquire iCAD for $103M in All-Stock Transaction

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |